[1] Dean E. Chronic obstructive pulmonary disease[J]. Nurs Older People, 2017, 29(4):12. DOI: 10.7748/nop.29.4.12.s14.
[2] Singh D, Agusti A, Anzueto A, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019[J]. Eur Respir J, 2019, 53(5):1900164. DOI: 10.1183/13993003.00164-2019.
[3] Viniol C, Vogelmeier CF. Exacerbations of COPD[J]. Eur Respir Rev, 2018, 27(147):170103. DOI: 10.1183/16000617.0103-2017.
[4] Yildiz BP, Bayraktaroglu M, Gunen H. Bronchodilator efficacy of tiotropium/formoterol (18/12 µg once daily via a Discair inhaler), tiotropium alone (18 µg by Handihaler) or combined with formoterol (12 µg twice daily by Aerolizer) in adults with moderate-to-severe stable COPD[J]. Curr Med Res Opin, 2019, 35(12):2187-2196. DOI: 10.1080/03007995.2019.1654722.
[5] 蔡柏蔷,李龙芸.协和呼吸病学[M].2版.北京:中国协和医科大学出版社,2016.
[6] Lim KE, Kim SR, Kim HK, et al. Symptom clusters and quality of life in subjects with COPD[J]. Respir Care, 2017, 62(9):1203-1211. DOI: 10.4187/respcare.05374.
[7] 周阳.COPD患者正念水平、应对方式与生活质量的相关研究[D]. 青岛:青岛大学,2018.
[8] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等.慢性阻塞性肺疾病基层诊疗指南(实践版•2018)[J].中华全科医师杂志,2018,17(11):871-877. DOI:10.3760/cma.j.issn.1671-7368.2018.11.003.
[9] 田媛,王至婉.支气管扩张症生存质量常用问卷[J].光明中医,2020,35(9):1316-1318. DOI:10.3969/j.issn.1003- 8914.2020.09.016.
[10] Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study[J]. Lancet, 2018, 391(10131):1706-1717. DOI: 10.1016/S0140-6736(18)30841-9.
[11] Meys R, Stoffels AAF, Houben-Wilke S, et al. Association between patient-reported outcomes and exercise test outcomes in patients with COPD before and after pulmonary rehabilitation[J]. Health Qual Life Outcomes, 2020, 18(1):300. DOI: 10.1186/s12955-020-01505-x.
[12] Ho T, Cusack RP, Chaudhary N, et al. Under- and over-diagnosis of COPD: a global perspective[J]. Breathe (Sheff), 2019, 15(1):24-35. DOI: 10.1183/20734735. 0346-2018.
[13] 王林宣,顾文超,吴浩,等.心率储备指导慢性阻塞性肺疾病稳定期患者个体化运动康复的临床观察[J].临床和实验医学杂志,2019,18(24):2655-2659. DOI:10.3969/j.issn. 1671-4695.2019.24.022.
[14] 任在方,张霞,侯改华,等.太极禅对慢性阻塞性肺疾病运动能力及生活质量的影响[J].中华中医药杂志,2017,32(8):3507-3510.
[15] 赵蕾.肠内营养联合肺康复训练对COPD患者营养状况及生活质量的影响[J].国际医药卫生导报,2020,26(21):3321-3325. DOI:10.3760/cma.j.issn.1007-1245. 2020. 21.039.
[16] Miłkowska-Dymanowska J, Białas AJ, Obrębski W, et al. A pilot study of daily telemonitoring to predict acute exacerbation in chronic obstructive pulmonary disease[J]. Int J Med Inform, 2018, 116:46-51. DOI: 10.1016/j.ijmedinf.2018.04.013.
[17] Eapen MS, Myers S, Lu W, et al. sE-cadherin and sVE-cadherin indicate active epithelial/endothelial to mesenchymal transition (EMT and EndoMT) in smokers and COPD: implications for new biomarkers and therapeutics[J]. Biomarkers, 2018, 23(7):709-711. DOI: 10.1080/1354750X.2018.1479772.
[18] 朱利月,任爱华,寿晓玲.CPET评估制定运动处方指导下的有氧运动对COPD患者心肺功能的影响[J].心脑血管病防治,2017,17(6):470-472. DOI:10.3969/j.issn.1009- 816x.2017.06.18.
[19] Pereira ACAC, Xavier RF, Lopes AC, et al. The mini-balance evaluation system test can predict falls in clinically stable outpatients with COPD: a 12-mo prospective cohort study[J]. J Cardiopulm Rehabil Prev, 2019, 39(6):391-396. DOI: 10.1097/HCR.0000000000000427.
[20] 孔晓红,谢剑玲,冼春燕,等.肺康复护理对COPD稳定期患者肺功能及生活质量的影响[J].中国实用医药,2021,16(4):199-201. DOI:10.14163/j.cnki.11-5547/r.2021.04.084.
[21] 柴晶艳,席中原.肺康复运动训练对COPD稳定期患者肺功能的临床影响[J].中国卫生标准管理,2021,12(17):65-67. DOI:10.3969/j.issn.1674-9316.2021.17.021.
[22] 王颖颖.心肺康复运动训练对COPD稳定期患者肺功能的影响[J].中外医疗,2021,40(13):62-64. DOI:10.16662/j.cnki.1674-0742.2021.13.062.
[23] Patsouras A, Farmaki P, Garmpi A, et al. Screening and risk assessment of coronary artery disease in patients with type 2 diabetes: an updated review[J]. In Vivo, 2019, 33(4):1039-1049. DOI: 10.21873/invivo.11572.
[24] 唐瑞红,安勇鹏.COPD稳定期患者营养状况对肺功能及生活质量的影响[J].中国卫生工程学,2019,18(6):911-913.
[25] 蒋雪莲,钟萍,黄成亮,等.稳定期慢性阻塞性肺疾病患者营养状况和氧化应激能力与肺功能的关系[J].中华结核和呼吸杂志,2017,40(1):40-45. DOI:10.3760/cma.j.issn.1001- 0939.2017.01.009.
|